Edward V. Nunes

20.6k total citations · 3 hit papers
378 papers, 13.8k citations indexed

About

Edward V. Nunes is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, Edward V. Nunes has authored 378 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 193 papers in Epidemiology, 145 papers in Public Health, Environmental and Occupational Health and 91 papers in Pharmacology. Recurrent topics in Edward V. Nunes's work include Substance Abuse Treatment and Outcomes (184 papers), Opioid Use Disorder Treatment (135 papers) and Treatment of Major Depression (62 papers). Edward V. Nunes is often cited by papers focused on Substance Abuse Treatment and Outcomes (184 papers), Opioid Use Disorder Treatment (135 papers) and Treatment of Major Depression (62 papers). Edward V. Nunes collaborates with scholars based in United States, Canada and United Kingdom. Edward V. Nunes's co-authors include Frances R. Levin, Deborah S. Hasin, Adam Bisaga, Martina Pavlicová, Efrat Aharonovich, Mei‐Chen Hu, Kenneth M. Carpenter, Maria A. Sullivan, Vito Agosti and Aimee Campbell and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Edward V. Nunes

365 papers receiving 13.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

2011 400 citations Edward V. Nunes et al. profile →
Development of a Cascade of Care for responding to the opioid epidemic

2019 227 citations Arthur Robin Williams, Edward V. Nunes et al. profile →
Bupropion and Naltrexone in Methamphetamine Use Disorder

2021 147 citations Udi E. Ghitza, Susan C. Sonne et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Edward V. Nunes

Since Specialization

Citations

This map shows the geographic impact of Edward V. Nunes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward V. Nunes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward V. Nunes more than expected).

Fields of papers citing papers by Edward V. Nunes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward V. Nunes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward V. Nunes. The network helps show where Edward V. Nunes may publish in the future.

Co-authorship network of co-authors of Edward V. Nunes

This figure shows the co-authorship network connecting the top 25 collaborators of Edward V. Nunes. A scholar is included among the top collaborators of Edward V. Nunes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward V. Nunes. Edward V. Nunes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dosing to Effect With Weekly and Monthly Subcutaneous and Daily Sublingual Buprenorphine: Post Hoc Analysis of a Phase 3 Clinical Trial 2025 ·Journal of Addiction Medicine ·Michelle R. Lofwall, Edward V. Nunes, Sharon Walsh, Genie L. Bailey, Michael Frost, (unknown), (unknown), (unknown), Peter Almgren, Stefan Peterson, Fredrik Tiberg	1
2	State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID‐19 onset 2025 ·Addiction ·(unknown), Arthur Robin Williams, Mei‐Chen Hu, Marc Scott, Maureen T. Stewart, (unknown), (unknown), Magdalena Cerdá, John Rotrosen, Edward V. Nunes, Noa Krawczyk	1
3	Comparative effectiveness of extended‐release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients 2024 ·Addiction ·Rachael K. Ross, Edward V. Nunes, (unknown), Matisyahu Shulman, Noa Krawczyk, Elizabeth A. Stuart, Kara E. Rudolph	6
4	Examining the Impact of the Innovative Opioid Court Model on Treatment Access and Court Outcomes for Court Participants 2024 ·Journal of Addiction Medicine ·Katherine S. Elkington, (unknown), Cale Basaraba, (unknown), (unknown), Melanie M. Wall, Alejandra García, (unknown), Howard Andrews, Edward V. Nunes	1
5	Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances 2023 ·Drug and Alcohol Dependence ·Felipe Castillo, Mei‐Chen Hu, Ying Liu, Raymond R. Balise, Roger D. Weiss, John Rotrosen, Edward V. Nunes, Andrew J. Saxon, Daniel J. Feaster, Sean X. Luo	2
6	Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial 2023 ·Journal of Addiction Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alain H. Litwin, Frances R. Levin, Kathleen T. Brady, Edward V. Nunes, Sandra A. Springer	9
7	Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOT 2023 ·Journal of Addiction Medicine ·(unknown), Jennifer Scodes, Martina Pavlicová, Tse‐Hwei Choo, (unknown), Angela M. Haeny, (unknown), Taeho Greg Rhee, John Rotrosen, Edward V. Nunes, Kathryn Hawk, E. Jennifer Edelman	0
8	Exploring the performance of during-treatment substance use outcome measures in predicting longer-term psychosocial functioning and post-treatment abstinence 2023 ·Drug and Alcohol Dependence ·Laura Brandt, Mei‐Chen Hu, Edward V. Nunes, Aimee Campbell	2
9	Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone 2022 ·Substance Use & Misuse ·(unknown), Matisyahu Shulman, Jennifer Scodes, Tse‐Hwei Choo, Martina Pavlicová, (unknown), Aimee Campbell, Patricia Novo, Marc Fishman, (unknown), John Rotrosen, Edward V. Nunes	3
10	Safety and Efficacy of a Digital Therapeutic for Substance use Disorder: Secondary Analysis of Data from a NIDA Clinical Trials Network Study 2022 ·Substance Abuse ·(unknown), Edward V. Nunes, Aimee Campbell, Jeffrey Botbyl, Hilary F. Luderer	10
11	Factors Influencing Buprenorphine Prescribing among Physicians in New York State 2019 ·SHILAP Revista de lepidopterología ·Leslie Marino, Aimee Campbell, Edward V. Nunes, Lloyd I. Sederer, Lisa B. Dixon	13
12	How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis 2018 ·Drug and Alcohol Dependence ·Frances R. Levin, C. Jean Choi, Martina Pavlicová, John J. Mariani, Amy L. Mahony, Daniel J. Brooks, Edward V. Nunes, John Grabowski	19
13	Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders 2016 ·New England Journal of Medicine ·Joshua D. Lee, Peter D. Friedmann, Timothy W. Kinlock, Edward V. Nunes, Tamara Y. Boney, Randall Hoskinson, Donna Wilson, Ryan McDonald, John Rotrosen, Marc N. Gourevitch, Michael Gordon, Marc Fishman, Donna T. Chen, Richard J. Bonnie, James Cornish, Sean M. Murphy, Charles P. O’Brien	225
14	Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial 2016 ·Drug and Alcohol Dependence ·Sean M. Murphy, Aimee Campbell, Udi E. Ghitza, Tiffany Kyle, Genie L. Bailey, Edward V. Nunes, Daniel Polsky	40
15	Contingency Management Abstinence Incentives: Cost and Implications for Treatment Tailoring 2015 ·Journal of Substance Abuse Treatment ·(unknown), Maxine L. Stitzer, Aimee Campbell, Martina Pavlicová, (unknown), Edward V. Nunes	13
16	Characteristics of an Outpatient Treatment Sample by Primary Substance of Abuse 2013 ·Journal of Addiction Medicine ·Aimee Campbell, Edward V. Nunes, Erin A. McClure, Mei‐Chen Hu, Eva Turrigiano, Bruce Goldman, (unknown)	11
17	Imaging Dopamine Transmission in Cocaine Dependence: Link Between Neurochemistry and Response to Treatment 2011 ·American Journal of Psychiatry ·Diana Martínez, Kenneth M. Carpenter, Fei Liu, Mark Slifstein, Allegra Broft, (unknown), Dileep Kumar, Ronald Van Heertum, Herbert D. Kleber, Edward V. Nunes	166
18	Treatment of Co-occurring Depression and Substance Dependence: Using Meta-analysis to Guide Clinical Recommendations 2008 ·Psychiatric Annals ·Edward V. Nunes, Frances R. Levin	14
19	Implementation of a Smoking Cessation Treatment Study at Substance Abuse Rehabilitation Programs: Smoking Behavior and Treatment Feasibility Across Varied Community-based Outpatient Programs 2007 ·Journal of Addiction Medicine ·Malcolm S. Reid, (unknown), Susan C. Sonne, Edward V. Nunes, (unknown), Huiping Jiang, (unknown), (unknown), Cynthia L. Arfken, (unknown), (unknown), Joan A. Muir, (unknown), Amy M. Loree, (unknown), Louis A. Giordano, James Robinson, John Rotrosen	17
20	Dopaminergic sensitivity and cocaine abuse: Response to apomorphine 1990 ·Psychiatry Research ·Eric Hollander, Edward V. Nunes, Concetta DeCaria, Frederic M. Quitkin, Thomas B. Cooper, Steven Wager, Donald F. Klein	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact